Cargando…
MEIS-1 level in unresectable hepatocellular carcinoma can predict the post-treatment outcomes of radiofrequency ablation
Radiofrequency ablation (RFA) is a local-ablative therapy for unresectable hepatocellular carcinoma (HCC). At present, there is no predictive marker for RFA treatment outcomes. This work aimed to valuate myeloid ecotropic viral integration site 1 (MEIS-1) in predicting post-RFA treatment outcomes of...
Autores principales: | Xie, Hui, Yu, Haipeng, Tian, Shengtao, Yang, Xueling, Wang, Ximing, Wang, Huaming, Guo, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880601/ https://www.ncbi.nlm.nih.gov/pubmed/29632641 http://dx.doi.org/10.18632/oncotarget.24165 |
Ejemplares similares
-
What is the best combination treatment with transarterial chemoembolization of unresectable hepatocellular carcinoma? a systematic review and network meta-analysis
por: Xie, Hui, et al.
Publicado: (2017) -
A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma
por: Xie, Hui, et al.
Publicado: (2018) -
Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience
por: Kalra, Naveen, et al.
Publicado: (2013) -
Role of Radiofrequency Ablation in the Management of Unresectable Pancreatic Cancer
por: Yousaf, Muhammad Nadeem, et al.
Publicado: (2021) -
Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria
por: Zhang, Lan, et al.
Publicado: (2014)